VOLTAN, Rebecca
 Distribuzione geografica
Continente #
NA - Nord America 6.284
AS - Asia 2.797
EU - Europa 2.266
SA - Sud America 548
AF - Africa 65
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.966
Nazione #
US - Stati Uniti d'America 6.182
SG - Singapore 1.107
CN - Cina 795
IT - Italia 716
BR - Brasile 467
DE - Germania 363
PL - Polonia 278
HK - Hong Kong 272
UA - Ucraina 232
GB - Regno Unito 197
TR - Turchia 190
VN - Vietnam 187
FI - Finlandia 105
RU - Federazione Russa 81
SE - Svezia 67
ID - Indonesia 66
CA - Canada 55
NL - Olanda 52
FR - Francia 44
IN - India 39
MX - Messico 39
AR - Argentina 36
JP - Giappone 31
ZA - Sudafrica 31
BD - Bangladesh 20
ES - Italia 20
LT - Lituania 19
CZ - Repubblica Ceca 17
BE - Belgio 14
EE - Estonia 13
EC - Ecuador 12
AT - Austria 11
IQ - Iraq 11
PK - Pakistan 10
KR - Corea 9
CL - Cile 8
IE - Irlanda 8
UZ - Uzbekistan 8
DZ - Algeria 7
RO - Romania 7
VE - Venezuela 7
CO - Colombia 6
IR - Iran 6
MA - Marocco 6
AL - Albania 5
CY - Cipro 5
KE - Kenya 5
TN - Tunisia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
GE - Georgia 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TZ - Tanzania 3
UY - Uruguay 3
CR - Costa Rica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
OM - Oman 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.966
Città #
Fairfield 722
Ashburn 678
Singapore 604
Woodbridge 603
Houston 402
Beijing 325
Chandler 303
Seattle 291
Ferrara 281
Ann Arbor 279
Warsaw 272
Hong Kong 269
Cambridge 268
Jacksonville 268
Santa Clara 267
Wilmington 247
Dallas 243
Munich 122
Los Angeles 119
New York 102
Izmir 89
Nanjing 81
Boardman 73
Princeton 61
Milan 60
Jakarta 57
Ho Chi Minh City 53
Bologna 48
Turku 47
San Diego 46
São Paulo 46
Shanghai 45
London 36
Hanoi 30
Dong Ket 29
Brooklyn 28
Mexico City 28
Falls Church 27
Buffalo 25
Chicago 25
Poplar 25
The Dalles 25
Bremen 24
Denver 24
Johannesburg 24
Rome 23
Tokyo 23
Nanchang 22
Shenyang 20
Mersin 19
Toronto 19
Frankfurt am Main 18
Hebei 18
Boston 17
Istanbul 17
Montreal 17
Rio de Janeiro 17
Dearborn 16
Hefei 16
Brno 15
Phoenix 15
Brussels 14
Changsha 14
Chennai 14
Norwalk 13
Tallinn 13
Tianjin 13
Atlanta 12
Brasília 12
Council Bluffs 12
Kunming 12
San Francisco 12
Washington 12
Ankara 11
Moscow 11
Jiaxing 10
Orem 10
Stockholm 10
Florence 9
Helsinki 9
Mountain View 9
Orange 9
Parma 9
Tappahannock 9
Turin 9
Auburn Hills 8
Curitiba 8
Da Nang 8
Guangzhou 8
Naples 8
New Delhi 8
Nuremberg 8
Redwood City 8
Tashkent 8
Amsterdam 7
Columbus 7
Haiphong 7
Hải Dương 7
Imola 7
Manchester 7
Totale 8.395
Nome #
Netter's Introduzione all'imaging 286
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 254
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 242
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 236
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 228
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 218
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 215
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 213
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 207
Antitumoral activity of Asparagus officinalis extracts against breast cancer 206
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 204
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 200
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 197
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 194
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 194
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 190
Actively targeted nanocarriers for drug delivery to cancer cells 190
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 186
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 186
Clinical perspectives of TRAIL: Insights into central nervous system disorders 183
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 177
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 174
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 174
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 172
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 168
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 164
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 162
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 147
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 146
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 144
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 143
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 143
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 143
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 134
Live recombinant vectors for AIDS vaccine development 131
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 131
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 130
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 129
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 129
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity 127
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 126
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 124
p53 and merlin tumor suppressors: Two of a kind 120
In Vitro Skin sensitisation analysis by the U-SENS method for new molecules innovative materials and medical devices 116
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 113
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 110
Nutlin-3a-loaded ethosomes as an efficient nanodelivery system target p53 in melanoma 104
null 103
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 102
null 101
null 100
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 98
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 98
null 97
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 96
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 96
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 94
null 94
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 94
null 92
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 91
null 90
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 90
null 90
null 89
null 88
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 88
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 87
null 86
null 86
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 85
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 84
null 84
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 84
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 84
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 83
null 83
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 81
null 81
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 81
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 79
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 78
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 76
null 74
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 67
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 65
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 65
Role of miRNA in adult ocular tumorigenesis 64
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 60
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 60
null 55
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 54
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 52
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 45
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 45
null 43
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 42
null 42
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 40
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 38
Totale 12.134
Categoria #
all - tutte 53.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021874 0 0 0 0 0 139 93 136 58 238 131 79
2021/2022719 25 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/20252.332 62 75 174 121 296 201 126 130 380 185 301 281
2025/20263.211 579 383 532 765 857 95 0 0 0 0 0 0
Totale 12.177